Alongside serving as the Inaugural Chancellor at RBHS, Dr. Strom is heavily involved in pharmacoepidemiological research. He is considered one of the founders of this field, which studies the effects of drugs on populations. Uniquely, Dr. Strom was one of the first to integrate large automated databases in epidemiological research. One example of how Dr. Strom has impacted medicine and epidemiology is through his research he was able to reverse 50 years’ worth of medical policy on the use of antibiotics to prevent infective endocarditis.

Dr. Strom is also a prominent member at the following committees and organizations. Included are the Board of Regents of the American College of Physicians, the Board of Directors of the American Society for Clinical Pharmacology and Therapeutics, and the Board of Directors for the American College of Epidemiology, the Board of Directors for the Association for Patient-Oriented Research, and the Board of Directors for the Clinical Research Forum. He was previously President of the International Society for Pharmacoepidemiology and the Association for Clinical Research Training. He served on the Drug Utilization Review Committee and the Gerontology Committee of the United States Pharmacopoeia, served on the founding Drug Safety and Risk Management Advisory Committee for the US Food and Drug Administration. He chaired multiple Institute of Medicine (IOM) (now National Academy of Medicine) committees, including the Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Committee on Smallpox Vaccine Program Implementation, Committee to Review NIOSH’s Traumatic Injury Program, the Committee on the Consequences of Reducing Sodium in the Population, Committee on a National Strategy for the Elimination of Hepatitis B and C, and the Committee on Development of a Protocol to Evaluate the Concomitant Prescribing of Opioid and Benzodiazepine Medications and Veterans Deaths and Suicides. He was a member of the IOM Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program the IOM Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, and the IOM Drug Forum.